Article
Accessible mutational trajectories for the evolution of pyrimethamine resistance in the malaria parasite Plasmodium vivax.
Journal of molecular evolution - 1 Sept 2013
Jiang Pan-Pan, Corbett-Detig Russell B, Hartl Daniel L, Lozovsky Elena R
Abstract excerpt
Antifolate antimalarials, such as pyrimethamine, have experienced a dramatic reduction in therapeutic efficacy as resistance has evolved in multiple malaria species. We present evidence from one such species, Plasmodium vivax, which has experienced sustained selection for pyrimethamine resistance at the dihydrofolate reductase (DHFR) locus since the 1970s. Using a transgenic Saccharomyces cerevisiae model...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
